Logashvari Naidoo

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Jared M. Baeten, Thesla Palanee‐Phillips, Elizabeth R. Brown et al. · Obstetrical & Gynecological Survey · 2016 · 373 citations

Gynecology, Social Sciences, Hiv-1 Infection Incidence +16

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Linda‐Gail Bekker, Moupali Das, Quarraisha Abdool Karim et al. · New England Journal of Medicine · 2024 · 358 citations

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi et al. · The Lancet HIV · 2021 · 108 citations · Full text

Sexual Health, Preventive Medicine, Hiv/aids Counselling +11

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

Cissy Kityo, Ivan Mambule, Joseph Musaazi et al. · The Lancet Infectious Diseases · 2024 · 81 citations · Full text

Sexual Health, Health Sciences, Treatment And Prevention +14

Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial

Thesla Palanee‐Phillips, Sarah T. Roberts, Krishnaveni Reddy et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2018 · 42 citations · Full text